Deal overview

Deal overview
Target IGM BIOSCIENCES INC (RIGHTS TO IGM ANTIBODIES)
Bidder SANOFI SA
Price £50.00 Full version or £25.00 Light version
Publication Date Mar 29, 2022
Abstract On 29 March 2022, the quoted French pharmaceutical company Sanofi SA ("Sanofi"), announced that its US subsidiary Genzyme Corporation ("GC") had entered into a worldwide collaboration agreement with the quoted US biotechnology company IGM Biosciences, Inc. ("IGM") to create, develop, manufacture, and commercialise IgM antibody agonists against three oncology targets and three ...
Number of pages (Full version) 5
Number of pages (Light version) 2
Format Adobe Acrobat (Download Acrobat Reader)
Free Sample Click Here to Download

Purchase this report

Accepted credit cards: Visa, America Express, Master Card

Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.

Search for Deals

Search over 70 million deal reports on more than 550,000 public and private companies. (copy)

Back to search results

Page Time: 0.017409s